Tue, 04 Oct 2022

NEW YORK, NY / ACCESSWIRE / August 8, 2022 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fulgent Genetics, Inc. (FLGT) ('Fulgent' or the 'Company') (NASDAQ:FLGT). Investors who purchased Fulgent securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/flgt.

Bronstein, Gewirtz and Grossman, LLC, Monday, August 8, 2022, Press release picture

The investigation concerns whether Fulgent has violated federal securities laws.

On August 4, 2022, Fulgent released its second quarter 2022 financial results, disclosing, among other items, that the U.S. Securities and Exchange Commission is conducting an investigation into certain reports for 2018 through the first quarter of 2020. The disclosure followed the Company's receipt of a civil investigative demand issued by the U.S. Department of Justice 'related to its investigation of allegations of medically unnecessary laboratory testing, improper billing for laboratory testing, and remuneration received or provided in violation of the Anti-Kickback Statute and the Stark Law.' On this news, Fulgent's stock price fell $11.02 per share, or 17.29%, over the following two trading sessions, to close at $52.72 per share on August 8, 2022.

If you are aware of any facts relating to this investigation or purchased Fulgent shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/flgt. You can also contact Peretz Bronstein or his Law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC



View source version on accesswire.com:
https://www.accesswire.com/711335/Bronstein-Gewirtz-Grossman-LLC-Notifies-Shareholders-of-Fulgent-Genetics-Inc-FLGT-Investigation

More Orlando News

Access More

Sign up for The Orlando News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!